Our Hottest Stories
Jeff Gerth is a senior reporter at ProPublica. Previously, he worked as an investigative reporter at The New York Times from 1976 through 2005. His work has twice been honored with the Pulitzer Prize. He also won a George Polk Award. His often-prescient coverage has run the gamut from Al Qaeda to Enron, from Whitewater to Chinese technology transfers. During 2004 he was a visiting professor at Princeton University, where he taught an undergraduate seminar on investigative reporting. Gerth is also the co-author (with Don Van Natta Jr.), of Her Way: The Hopes and Ambitions of Hillary Rodham Clinton, published in 2007.
Aug. 12, 8 a.m.Flow restrictors can help prevent children from taking too much acetaminophen, the active ingredient in Tylenol, which can cause liver damage if taken in high doses.
July 27, 2:22 p.m.The agency says doctors should consider limiting MRIs to reduce exposure from certain image-enhancing drugs that contain the metal gadolinium.
July 23, 1:34 p.m.A lawsuit can proceed against the company for allegedly failing to offer the required discounts to schools and libraries, says an appeals court.
July 15, 12:08 p.m.After an investigation by the Toronto Star, Canada’s top health agency considers whether to lower the maximum recommended daily dose of the active ingredient in Tylenol and other painkillers.
June 11, 11:22 a.m.Researchers raise alarms about unknown health risks of GE’s Omniscan and Bayer’s Magnevist, drugs injected to get better MRI pictures that contain the heavy metal gadolinium.
May 19, 5:15 a.m.Millions of Americans use GlaxoSmithKline's purple inhaler. But whether Advair poses a higher risk of asthma-related death remains uncertain 15 years after regulators approved the drug.
March 27, 3:45 p.m.Emails disclosed by a hacker show a close family friend was funneling intelligence about the crisis in Libya directly to the Secretary of State’s private account starting before the Benghazi attack.
March 13, 8 a.m.The latest flap over her private emails as secretary of state is far from the first time she's been accused of lacking transparency.
March 10, 6:28 p.m.Hillary Clinton defense of her use of personal emails while Secretary of State triggers memories of the ‘pink press conference’ during the Whitewater investigation.
Oct. 30, 2014, 5:25 a.m.The former Treasury secretary and architect of the Obama administration's financial rescue sounds more like some of his detractors in papers that were never meant to be public.
June 18, 2014, 11:40 a.m.In “Hard Choices,” the former secretary of state ignores or glosses over key aspects of her record on Iraq—including State Department responsibility for the country’s security assistance.
May 14, 2014, 12:37 p.m.The former treasury secretary says his close ties to ex-Citi executive Robert Rubin ‘tempered my skepticism’ about the bank’s health in the years before the financial crisis hit.
Feb. 27, 2014, 11:41 a.m.Federal regulators’ announcement that they will examine the regulation of non-prescription drugs such as acetaminophen, the active ingredient in Tylenol, follows a ProPublica investigation.
Jan. 16, 2014, 1:16 p.m.Federal drug regulators are moving to enforce a ban on prescription drugs with more than 325 milligrams of acetaminophen. But you’ll still be able to buy pills that contain up to twice that dose over-the-counter at the gas station or grocery store.
Dec. 30, 2013, 10 a.m.Safety valves that cost pennies per bottle could save thousands of kids from being rushed to emergency rooms each year. A doctor has campaigned to have the devices added to all liquid medicines, but so far he’s had limited success.
Sep. 23, 2013, 11:35 a.m.Most Americans know that overdosing can be dangerous but many wrongly think it’s safe to mix drugs containing acetaminophen, a nationwide poll found.
Sep. 20, 2013, 9:55 a.m.We explore the data behind figures showing how many people die from overdosing on acetaminophen, the active ingredient in Tylenol.
March 22, 2013, 2:41 p.m.A jury awarded $5 million to a patient and his wife after it found GE Healthcare didn’t adequately warn patients and doctors about the risk of its imaging dye, Omniscan. It was the first case involving the dye to go to trial.
March 7, 2013, 12:27 p.m.A groundbreaking trial over GE Healthcare's imaging dye Omniscan reveals new evidence that a rare but terrible side effect might have been downplayed. GE says the evidence is being twisted and that it acted ethically.
Feb. 12, 2013, 2:47 p.m.In a major win for the IRS, a federal tax court judge ruled that BNY Mellon improperly claimed foreign tax credits. The bank announced it would take an $850 million charge but that it would also appeal.
Safeguard the public interest.
Support ProPublica’s award-winning investigative journalism.